BROADCASTS.com

Published: March 28, 2017, 9:07 p.m.

b'Download Kevin is a science writer, graduate student researcher and aspiring clinician, harm reduction educator and substance use recovery advocate. Kyle and Joe talk to him about loads of\\xa0topics including early Iboga therapies, an early Boston Ibogaine Conference, his approach to journalism and his future aspirations to do future clinical work and research. Kevin\'s website

Kevin\'s writing

• Public Seminar (2016, The New School blog) -\\xa0Trump Calls Killing Addicts, "Right Approach"
• SSDP Blog (2016) -\\xa0Recovery and Reform: An Alum\'s Journey Back
• The Fix (2016)
  • \\xa0I Take Psychedelic Drugs and I\\u2019m in Recovery
• VICE (2016, 2015)
  • \\xa0Inside a Music Festival in a Country Where All Drugs Are Decriminalized
  • \\xa0Meet the Only Doctor in the World Legally Allowed to Use LSD to Treat Patients
• New Scientist (2016, 2014, 2013)
  • Magic Mushroom drug helps people with cancer face death
  • Putting healthcare first can save festival drug users from harm
  • \\xa0LSD\\u2019s ability to make minds malleable revisited
  • \\xa0Mind-altering drug could offer life free of heroin
• Reality Sandwich (2015)
  • Growing Pains: Reflections on the Current Psychedelic Renaissance
  • \\xa0A New Perspective: How Ibogaine Treatment Helped Turn My Life Around
• Ladybud (2015) \\u2013 Envisioning a Post-Prohibition World at Psymposia Psychedelics Conference
• Reset.me (2015, 2014)
  • Marine-Turned-Researcher Announces New Ayahuasca Study at Psychedelic Event
  • Psychedelics and the Origins of Christmas Folklore: An Interview with Professor Carl Ruck
  • Entering a Psychedelic State \\u2013 Without Psychedelics: Inside Holotropic Breathwork
• Reason.com (2014) \\u2013 Psychedelic Science\\xa0(Acid Test by Tom Shroder book review)

Staff Writer (Fall 2012\\u2013Spring 2013) -\\xa0NuScience Magazine, Northeastern University

• The Environmental Impacts of Anti-Drug Eradication: Plan Colombia (Issue 15)
• NU Science Interview with NU Professor Albert-Laszlo-Barabasi (Issue 16)
• MDMA for PTSD (Issue 13)

---

Links

• Dana Beal
• Carl Hart
• Kosmicare
• Gary Fisher - Papers
• Purdue
• Erowid

Autism 20-25 mg Psilocybin 200 mcg - LSD A Conversation Between Gary Fisher and Myron Stolaroff (2004) - Psychedelic Salon 2009 Ibogaine Conference Northeastern University, Boston, Mass. Alicia Danforth Ph.D -Dissertation National Geographic - Breakthrough\\xa0season 2

---

About Kevin:

Kevin graduated from Northeastern University in 2013 with a degree in neuroscience. As an undergraduate he completed an internship as a research assistant at Harvard Medical School working on the Phase 2 dose-response study investigating the therapeutic potential of MDMA-assisted psychotherapy for treatment of cancer related anxiety. Kevin was also one of the founders of the Northeastern chapter of Students for Sensible Drug Policy, and in 2009 the group hosted and co-sponsored the Boston Ibogaine Forum. He now lives in New York City where he is enrolled in a clinical psychology graduate program at The New School for Social Research and is pursuing a doctoral degree. Kevin has worked part-time for the Drug Policy Alliance, and also works as a writer covering topics related to psychedelic therapy, addiction, and mental health advocacy. His recent contributions include: New Scientist, Reason.com, Reset.me, Reality Sandwich, and VICE.com.'